Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
about
Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials.Clinical pharmacology profile of care in Hepatology clinic.
P2860
Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Incidence of and risk factors ...... ients with chronic hepatitis C
@ast
Incidence of and risk factors ...... ients with chronic hepatitis C
@en
type
label
Incidence of and risk factors ...... ients with chronic hepatitis C
@ast
Incidence of and risk factors ...... ients with chronic hepatitis C
@en
prefLabel
Incidence of and risk factors ...... ients with chronic hepatitis C
@ast
Incidence of and risk factors ...... ients with chronic hepatitis C
@en
P2093
P2860
P1476
Incidence of and risk factors ...... ients with chronic hepatitis C
@en
P2093
Hyung Min Yu
Jeong Han Kim
So Young Kwon
Won Hyeok Choe
Yong Hwang
P2860
P304
P356
10.3904/KJIM.2015.30.6.792
P577
2015-10-30T00:00:00Z